Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPA-4-FAP safety study of rapamycin in pediatric familial adenomatous polyposis
2024-512079-11-00Phase 2Authorised
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus in Colonic Adenomatous Polyposis, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Safety (AEs and SAEs). Planned start Sep 2024; status: authorised.
02
Drugs
sirolimus
03
Conditions
Colonic Adenomatous Polyposis
Beyond the preview
Go deeper on 2024-512079-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512079-11-00.